Real-Life Effectiveness of Infliximab in the Treatment of Rheumatoid Arthritis: The Canadian Experience

被引:0
|
作者
Choquette, Denis [1 ]
Bensen, William [2 ]
Khalil, Hayssam [3 ]
Sampalis, John [4 ]
机构
[1] Hop Notre Dame de Bon Secours, Montreal, PQ H2L 4K8, Canada
[2] McMaster Univ, Hamilton, ON L8S 4L8, Canada
[3] Schering Plough Canada, Montreal, PQ, Canada
[4] Univ Montreal, Westmount, PQ, Canada
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
26
引用
收藏
页码:1283 / 1283
页数:1
相关论文
共 50 条
  • [41] Treatment of rheumatoid arthritis with infliximab
    Schwebig, A
    Thriene, W
    AKTUELLE RHEUMATOLOGIE, 2000, 25 (03) : 93 - 96
  • [42] Infliximab in the treatment of rheumatoid arthritis
    Perdriger, A.
    BIOLOGICS-TARGETS & THERAPY, 2009, 3 : 183 - 191
  • [43] TREATMENT TO TARGET FOLLOWING INITIATION OF TREATMENT WITH RITUXIMAB IN RHEUMATOID ARTHRITIS: REAL LIFE EXPERIENCE
    Ionescu, R.
    Ismajli, M.
    Moore, S.
    Cambridge, G.
    Leandro, M.
    ANNALS OF THE RHEUMATIC DISEASES, 2016, 75 : 1031 - 1031
  • [44] Corticosteroid Use In Rheumatoid Arthritis Patients On Infliximab: Treatment Implications Based On A REAL-WORLD Canadian Population
    Haraoui, Boulos
    Jovaisas, Algis V.
    Bensen, William G.
    Faraawi, Rafat Y.
    Kelsall, John T.
    Dixit, Sanjay
    Rampakakis, Emmanouil
    Sampalis, John S.
    Nantel, Francois
    Otawa, Susan M.
    Lehman, Allen J.
    Shawi, May
    ARTHRITIS AND RHEUMATISM, 2013, 65 : S620 - S621
  • [45] CORTICOSTEROID USE IN RHEUMATOID ARTHRITIS PATIENTS ON INFLIXIMAB: TREATMENT IMPLICATIONS BASED ON A REAL-WORLD CANADIAN POPULATION
    Haraoui, B.
    Jovaisas, A.
    Bensen, W. G.
    Faraawi, R.
    Kelsall, J.
    Dixit, S.
    Rampakakis, E.
    Sampalis, J. S.
    Nantel, F.
    Otawa, S.
    Lehman, A. J.
    Shawi, M.
    ANNALS OF THE RHEUMATIC DISEASES, 2013, 72 : 224 - 224
  • [46] Real-life experience of tofacitinib in patients with treatment-resistant rheumatoid arthritis: A 5-year follow-up: Monocentric experience
    Pehlivan, Ozlem
    NORTHERN CLINICS OF ISTANBUL, 2022, 9 (04) : 376 - 384
  • [47] Cost-effectiveness of infliximab in the treatment of rheumatoid arthritis in clinical practice
    Virkki, L. M.
    Konttinen, Y. T.
    Peltomaa, R.
    Suontama, K.
    Saario, R.
    Immonen, K.
    Jantti, J.
    Tuomiranta, T.
    Nykanen, P.
    Hameenkorpi, R.
    Heikkila, S.
    Isomaki, P.
    Nordstrom, D.
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2008, 26 (06) : 1059 - 1066
  • [48] Quality of life among outpatients with rheumatoid arthritis in a real-life setting in Germany
    Deeg, M.
    Langer, H. E.
    Langer, A.
    Wasem, J.
    VALUE IN HEALTH, 2008, 11 (03) : A265 - A265
  • [49] Apremilast for the treatment of active psoriatic arthritis: a single-centre real-life experience
    Abignano, Giuseppina
    Fadl, Nafisa
    Merashli, Mira
    Wenham, Claire
    Freeston, Jane
    McGonagle, Dennis
    Marzo-Ortega, Helena
    RHEUMATOLOGY, 2018, 57 (03) : 578 - 580
  • [50] Outcomes of Infliximab Treatment in Canadian Rheumatoid Arthritis Patients of Different Age Groups
    Faraawi, Rafat
    Baker, Milton
    Bensen, William
    Rampakakis, Emmanouil
    Sampalis, John
    Otawa, Susan
    JOURNAL OF RHEUMATOLOGY, 2012, 39 (08) : 1719 - 1720